Literature DB >> 356569

Spironolactone.

H R Ochs, D J Greenblatt, G Bodem, T W Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 356569     DOI: 10.1016/0002-8703(78)90052-2

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  19 in total

1.  Effect of fludrocortisone and spironolactone on sodium and potassium losses in secretory diarrhea.

Authors:  H H Wenzl; K D Fine; C A Santa Ana; J L Porter; J S Fordtran
Journal:  Dig Dis Sci       Date:  1997-01       Impact factor: 3.199

2.  Effect of spironolactone on acid and alkaline phosphatase in the testes of albino rat.

Authors:  P K Singh; D P Singh
Journal:  Indian J Clin Biochem       Date:  2005-01

Review 3.  Corticosteroid receptor antagonists: a current perspective.

Authors:  W Sutanto; E R de Kloet
Journal:  Pharm World Sci       Date:  1995-03-24

4.  Systolic time intervals during spironolactone treatment of digitalized and non-digitalized patients with ischaemic heart disease.

Authors:  S Waldorff; J Berning; J Buch; E Steiness
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

5.  Comparison of single and divided daily dose spironolactone in the control of hypertension.

Authors:  G M Bell; L Fananapazir; J L Anderton
Journal:  Br J Clin Pharmacol       Date:  1981-10       Impact factor: 4.335

6.  Pharmacokinetics of metoprolol in patients with hepatic cirrhosis.

Authors:  C G Regårdh; L Jordö; M Ervik; P Lundborg; R Olsson; O Rönn
Journal:  Clin Pharmacokinet       Date:  1981 Sep-Oct       Impact factor: 6.447

7.  Quantitative comparison of aldosterone antagonists in normal human subjects: prediction of therapeutic potency.

Authors:  G T McInnes; I R Harrison; J R Shelton; R M Perkins
Journal:  Br J Clin Pharmacol       Date:  1981-11       Impact factor: 4.335

8.  Relative potency and structure activity relationships of aldosterone antagonists in healthy man: correlation with animal experience.

Authors:  G T McInnes; J R Shelton; L E Ramsay; I R Harrison; M J Asbury; J M Clarke; R M Perkins; G R Venning
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

9.  Spironolactone dose-response relationships in healthy subjects.

Authors:  G T McInnes; R M Perkins; J R Shelton; I R Harrison
Journal:  Br J Clin Pharmacol       Date:  1982-04       Impact factor: 4.335

10.  Amiloride improves hemodynamics in patients with chronic congestive heart failure treated with chronic digoxin and diuretics.

Authors:  M D Cheitlin; R Byrd; N Benowitz; E Liu; G Modin
Journal:  Cardiovasc Drugs Ther       Date:  1991-08       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.